Shiseido Future Solution Lx Infinite Treatment Primer 58411-0657
Generic: Titanium Dioxide, Octinoxate, And Ensulizole
Product NDC
58411-0657- Manufacturer
- Shiseido Americas Corporation
- Dosage Form
- Emulsion
- Route
- Topical
- Product Type
- Human Otc Drug
- Marketing Start
- May 1, 2021
- Listing Expires
- December 31, 2027
- Application
- M020
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ensulizole | .428 g/40mL |
| Octinoxate | 1.71 g/40mL |
| Titanium Dioxide | 1.77 g/40mL |
Packaging Options(1)
1 TUBE in 1 CARTON (58411-657-10) / 40 mL in 1 TUBE